Alexandre Acramel,*, Sandy Blondeel-Gomes, Carla Matta, Subramanian Narayani, Olivier Madar, Romain Desmaris, Laurence Escalup and
J Fouque - Qualitative and Quantitative Risk Assessment of …, 2023 - books.google.com
Antineoplastic drugs (ADs) are still the standard treatment of cancer by acting on dividing
cells to inhibit the uncontrolled reproduction of cancer cells but also on healthy cells by a …
cells to inhibit the uncontrolled reproduction of cancer cells but also on healthy cells by a …
[HTML][HTML] Reporting environmental contamination results to healthcare workers could play a crucial role in decreasing the risk of occupational exposure to …
A Acramel, S Blondeel-Gomes, C Matta… - Frontiers in Public …, 2022 - frontiersin.org
Antineoplastic drugs (ADs) are still the standard treatment of cancer by acting on dividing
cells to inhibit the uncontrolled reproduction of cancer cells but also on healthy cells by a …
cells to inhibit the uncontrolled reproduction of cancer cells but also on healthy cells by a …
[PDF][PDF] Hazardous substances in the workplace
M West - 2008 - researchgate.net
This definition offers a challenge to those charged with the assessment of hazardous
chemical substances in the workplace. The first step to meet the challenge is the recognition …
chemical substances in the workplace. The first step to meet the challenge is the recognition …
[图书][B] Cancer risks of nurses to assess the carcinogenic potential of antineoplastic drugs
JB Hewitt - 1992 - search.proquest.com
Abstract Nurses'(N= 13,587) occupational cancer risks were compared first to teachers (N=
37,160), then to all women except nurses (which included teachers)(N= 289,748), using …
37,160), then to all women except nurses (which included teachers)(N= 289,748), using …
How to deal with uncertainties regarding the occupational exposure to antineoplastic mixtures: additive effect should always be considered?
Risk assessment considerations-The concept that “safe levels of exposure” for humans can
be identified for individual chemicals is central to the risk assessment of compounds with …
be identified for individual chemicals is central to the risk assessment of compounds with …
On assessment of hazards to health at work
SA Roach - AIHA Journal, 1994 - search.proquest.com
Abstract The William P. Yant Award is presented to recognize outstanding contributions in
industrial hygiene or allied fields made by an individual residing outside the US. An address …
industrial hygiene or allied fields made by an individual residing outside the US. An address …
[PDF][PDF] Cancer risk assessment: present and future.
W Szymczak… - International Journal of …, 2005 - oldwww.imp.lodz.pl
Risk assessment is a process based on available scientific information about properties of a
given agent, and its effect on biological processes to evaluate potential adverse …
given agent, and its effect on biological processes to evaluate potential adverse …
Preventing occupational exposures to antineoplastic drugs in health care settings
TH Connor, MA McDiarmid - CA: a cancer journal for clinicians, 2006 - Wiley Online Library
The toxicity of antineoplastic drugs has been well known since they were introduced in the
1940s. Because most antineoplastic drugs are nonselective in their mechanism of action …
1940s. Because most antineoplastic drugs are nonselective in their mechanism of action …
Public health policy activity on the safe handling of hazardous anti-cancer drugs in the healthcare workplace
MA McDiarmid - European Journal of Oncology, 2004 - pure.johnshopkins.edu
The foundation of modern cancer chemotherapy, antineoplastic agents comprise several
drug classes which achieve their therapeutic action largely through binding to cellular …
drug classes which achieve their therapeutic action largely through binding to cellular …
Handling anticancer drugs: from hazard identification to risk management?
M Sorsa, M Haemeilae… - Annals of the New York …, 2006 - Wiley Online Library
The potential health hazards involved with antineoplastic agents have been known for
decades. Many anticancer drugs are recognized as carcinogens and genotoxins in …
decades. Many anticancer drugs are recognized as carcinogens and genotoxins in …